Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study (Q36616523)
Jump to navigation
Jump to search
scientific article published on March 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study |
scientific article published on March 2005 |
Statements
1 reference
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study (English)
1 reference
E Van Cutsem
1 reference
L Dirix
1 reference
J-L Van Laethem
1 reference
S Van Belle
1 reference
M Borner
1 reference
M Gonzalez Baron
1 reference
A Roth
1 reference
R Morant
1 reference
E Joosens
1 reference
G Gruia
1 reference
D Sibaud
1 reference
H Bleiberg
1 reference
1 March 2005
1 reference
1 reference
1055-1062
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference